Skip to main content
. 2017 Oct 13;12:54. doi: 10.1186/s13027-017-0163-4

Table 4.

Risk of cancer progression or death according to HPV, p53 and p16 status

Model Variable of interesta Progression-free survival Specific-cancer survival
HR [CI95%] HR [CI95%]
1 HPV 1.042 [0.293: 3.709] 1.901 [0.926: 3.900]
2 p16 1.137 [0.383: 3.378] 1.268 [0.617: 2.604]
3 p53 1.318 [0.646: 2.689] 1.177 [0.726: 1.907]

aModel adjusted by sex. Clinical stage and treatment (surgery and chemoradiotherapy). HR: Hazard ratio